Oracle Corporation
ORCL · NYSE
ORCL · NYSE
Palantir Technologies Inc.$175.42
SAP SE ADS$229.80
Alphabet Inc. Depositary Shares representing a 1/20th Interest in a Share of Series A Mandatory Convertible Preferred Stock$41.99
Alphabet Inc. Depositary Shares representing a 1/20th Interest in a Share of Series B Mandatory Convertible Preferred Stock$40.84Oracle sells enterprise database and business software, cloud applications, cloud infrastructure, and related services. Its database heritage supports software licensing and support, while its cloud businesses provide subscription-based infrastructure and applications; the supplied material does not break out the revenue contribution of each. Customers are organizations using its software and computing services, including businesses moving workloads to cloud platforms. Oracle is also expanding AI infrastructure and multicloud offerings. In fiscal 2026, it reports $67.4 billion in revenue and $17.0 billion in net income, compared with $57.4 billion and $12.4 billion, respectively, in fiscal 2025.
Oracle gained 11.17%, from $125.54 to $139.56, over the supplied week. The main catalyst was its October 28 Investor Day, when Oracle set a fiscal 2030 revenue target of at least $225 billion and reaffirmed its fiscal 2027 outlook; shares jumped 10.73% that day on volume of 81.9 million shares. Plans to reach positive free cash flow and a pledge to raise no more than $20 billion in additional capital-market funding through fiscal 2030 also featured in the outlook. The stock gave back part of Wednesday’s surge on October 29, falling 3.45% to $139.56. Broader markets rose modestly on October 28 after the Federal Reserve held rates steady, but Oracle’s much larger move followed its company-specific guidance.
Oracle fell 5.68%, from $137.39 to $129.59, over the stated period. Shares first rose to $143.20 on Oct. 13, then reversed sharply, dropping to $130.55 on Oct. 14 on the week’s heaviest volume of 52.5 million shares. They recovered to $134.47 the next day, slid to $128.23 on Oct. 16, and edged up to $129.59 on Oct. 19. The supplied evidence does not establish a dated company-specific catalyst for those sessions. Coverage frames the pressure around worries over AI spending, debt financing and valuation, but the available headlines do not show that any one of those concerns drove the week’s sharp reversal.
Oracle fell 3.57%, from $142.48 to $137.39, as concerns about AI infrastructure spending and financing outweighed a sharp late-week recovery. Shares rose to $144.77 on Tuesday, then slipped Wednesday before dropping 5.5% Thursday to $135.69 on unusually heavy volume of 42.4 million shares. Coverage linked that selloff to growing AI buildout and debt worries, including a CoreWeave bond scare, alongside broader technology weakness and concerns that hotter inflation could keep rates high. Oracle rebounded 4.2% Friday to $141.40, recovering much of Thursday’s loss, but fell again on Monday. The supplied coverage points to sector and financing fears, rather than a specific Oracle earnings or guidance announcement, as the main pressure.
Oracle gained 5.07%, rising from $137.79 on September 29 to $144.77 on October 6 across the supplied observations. The path was uneven at first: shares slipped to $137.30 on September 30, edged up October 1, then climbed $4.23 on October 2 on the largest volume in the listed sessions after September 29. The stock added another $2.47 over October 5 and 6, extending the advance rather than giving it back. The supplied evidence does not identify a company-specific catalyst within those trading dates, and it provides no market benchmark to explain the move as a sector or broader-market trend. Headlines about OpenAI revenue shortfalls and Oracle’s debt-funded AI chip buying refer to later reports and do not explain this observed week.
ORCL finished at $138.07, down 1.05% from the supplied $139.54 reference close; however, those prices span Sep. 24 to Oct. 1, not just the week beginning Sep. 28. Within that week, shares rose from Monday’s $132.60 close to Thursday’s $138.07. The sharp Monday drop extended pressure amid concerns about potential data-center delays, which had weighed on the stock the prior week. On Tuesday, shares rebounded 3.91% to $137.79 after Oracle released Fusion Claw, an agentic AI feature for its Fusion applications, clawing back much of Monday’s loss. Shares then eased slightly over Wednesday and Thursday, but held most of Tuesday’s recovery.
ORCL rose 0.98%, from $143.16 on September 16 to $144.56 on September 23, across the supplied close window. The biggest positive move came September 17, when shares gained 5.2%; coverage attributed the surge to strong first-quarter performance. The stock then gave back part of that advance, falling 2.0% on September 18, before modest gains on September 21 and 22 and a 3.1% drop on September 23. Coverage raised concerns about AI-related debt and data-center delays, including Oracle’s Project Jupiter, but the supplied closes end September 23. The reported force majeure notice is dated September 24, so it falls outside that price window and cannot explain its final-day decline.
Oracle fell $13.99, or 8.81%, from $158.78 to $144.79. The stock initially rose 2.4% to $162.52 before edging lower on September 9 and then reversing sharply, losing $8.69 on September 10, $2.66 on September 11 and another $5.49 on September 14. Selling volume expanded materially during the decline, reaching 56.8 million shares on September 10 and 80.4 million on September 11, versus 37.7 million during the earlier advance. The main pressures were concern over layoffs alongside billions of dollars of AI-related borrowing, questions about credit risk and whether large AI contracts will convert into revenue, and reported insider selling by CEO Safra Catz. Traders also watched for OpenAI funding and a potential Japan cloud deal as offsetting catalysts.
Oracle rose 8.99%, from $149.12 to $162.52, despite an early drop to $141.32 before recovering steadily. The main catalyst was strong first-quarter performance: reported revenue grew 30%, IaaS revenue increased 121%, and AI cloud demand was described as outpacing available supply. Management also raised guidance, reinforcing expectations that Oracle’s cloud growth has inflected. Barclays lifted its price target, while Oppenheimer reiterated Outperform, adding to the positive reaction. Oracle’s gains occurred even as broader markets faced pressure from surging oil prices and increased expectations for a September rate hike. Trading volume increased to 37.7 million shares on the final reported session, supporting the strength of the rebound.
Oracle gained 1.38% over the stated week, rising from $151.94 to $154.04, but the path was sharply volatile. Shares fell to $149.12 on Monday and then dropped 5.2% to $141.32 on Tuesday; the supplied evidence does not identify a company-specific cause for that selloff. The stock recovered to $145.75 on Wednesday and surged 5.7% on Thursday. The rebound was supported by broader technology and rate sentiment after Fed Governor Christopher Waller signaled support for holding rates steady if inflation improves, while coverage also highlighted Oracle’s HPE equipment deal, OpenAI’s Astra release and anticipation of the first-quarter earnings report. The week therefore ended well above Tuesday’s low.
Oracle rose 6.95%, from $142.07 to $151.94, gaining $9.87 over the week. The main catalyst was a broader technology rally after Nvidia’s earnings reinforced optimism about artificial-intelligence demand; the Nasdaq 100 rose 1.43% in the related session. Citigroup then doubled down on Oracle, arguing that the stock was worth $330 versus roughly $148, giving the advance a company-specific valuation catalyst. CEO Mike Sicilia’s comments that AI is reshaping cloud growth, pricing and enterprise demand added support. Trading was uneven initially: Oracle fell from $146.47 on August 21 to $142.45 on Monday, August 24, before advancing for three straight sessions. Volume reached 30.25 million shares on August 27, the week’s highest level.
Oracle fell $14.15, or 9.06%, from $156.22 to $142.07 over the reported week. The stock declined on each of the first two sessions, dropping to $146.65 on August 17 and $142.79 on August 18, before a modest 0.7% rebound on August 19 and a renewed 1.2% decline on August 20. The supplied evidence does not identify a dated company-specific announcement explaining the sequence. Instead, investor debate appears focused on the financing risks of Oracle’s AI data-center expansion versus its record backlog, cloud growth, expanded AWS database partnership and guidance. Broader AI-investment positioning may also have influenced trading, but the evidence does not quantify a market-wide catalyst or establish its relative importance.
Oracle gained $9.20, or 6.49%, from $141.85 to $151.05 across the supplied trading window. The stock jumped to $145.74 on Tuesday, then gave back part of that advance through Wednesday and Thursday, before rebounding to $147.02 on Friday and $151.05 on Monday. The strongest company-specific support came from reports that Oracle had entered a quantum partnership, alongside coverage portraying additional layoffs as a potential efficiency measure. Those positives outweighed recurring concerns about a prospective $40 billion funding requirement, rising debt and junk-bond risk, and doubts over whether AI infrastructure spending can earn adequate returns. The pattern therefore reflected a sharp reversal from financing and capital-intensity worries rather than a steady repricing on reported earnings.
Oracle rose $25.78, or 21.49%, from $119.96 to $145.74 over the supplied week. The advance followed a 1.85% decline on July 29, then accelerated with gains of 8.34% on July 30, 1.81% on July 31, 9.22% on August 3 and 2.74% on August 4. The first major driver was a broad risk-on session as Middle East tensions eased, lifting the S&P 500 1.48% and Nasdaq 100 1.78% on August 3. AI-sector optimism also supported the move, with evidence citing expanding capital expenditure, enterprise backlogs and strong margins. No company-specific announcement, earnings release or guidance change is identified in the supplied evidence; Oracle moved within a broader AI and market rally.